[1] Mobarak A, Dawoud H, Mokhtar WA, et.al Propionic and methylmalonic acidemias: Initial clinical and biochemical presentation[J]. Int J Pediatr, 2020,2020:7653716.
[2] 韩笑, 韩炳娟, 朱薇薇. 甲基丙二酸血症诊治及预后研究进展[J]. 中国实用儿科杂志, 2021, 36(6):463-468.
Han X, Han BY, Zhu WW. Progress in diagnosis and treatment and prognosis of methylmalonic acidemia[J]. Chin J Pract Pediatr, 2021,36 (6):463-468.
[3] Ferreira CR, Rahman S, Keller M, et al. An international classification of inherited metabolic disorders (ICIMD)[J]. J Inherit Metab Dis,2021, 44(1):164-177.
[4] 贺薷萱,董慧,张宏武,等.甲基丙二酸血症合并同型半胱氨酸尿症导致脑积水76例诊断和治疗分析[J].中华儿科杂志,2021,59(6):459-465.
He WX, Dong H, Zhang HW,et.al. Methylmalonic aemia combined with homocysteinuria led to hydrocephalus in 76 cases of diagnosis and treatment analysis[J]. Chin J Pediatr, 2021,59 (6): 459-465.
[5] 刘敏, 崔利丹, 王琪. 儿童危重型甲基丙二酸血症临床特点及基因分析[J]. 临床儿科杂志, 2019, 37(12):885-888.
Liu M, Cui LD, Wang Q. Clinical characteristics and genetic analysis of critical methylmalonic acidemia in children[J]. J Clin Ped, 2019,37 (12): 885-888.
[6] 靳有鹏,赵春,刘海燕,等. PICU危重甲基丙二酸血(尿)症十例临床分析并文献复习[J]. 中国小儿急救医学, 2015, 22(8):576-578.
Jin YP, Zhao C, Liu HY, et.al. Clinical analysis of ten cases of critical methylmalonic acid blood (urine) disease in PICU and literature review[J]. Pediatr Emerg Med Chin, 2015,22 (8):576-578.
[7] 贾立云,封纪珍,王熙,等. 甲基丙二酸血症合并同型半胱氨酸血症患儿基因突变分析[J]. 国际生殖健康/计划生育杂志,2019,38(5):362-366.
Jia LY, Feng JZ, Wang X, et al. Analysis of genetic mutations in children with methalanonic acidemia with homocysteinemia[J]. J Inter Reprod Health/Family Plan, 2019,38 (5): 362-366.
[8] Hu S, Kong X. The genotype analysis and prenatal genetic diagnosis among 244 pedigrees with methylmalonic aciduria in China[J].Taiwan J Obstet Gynecol, 2022, 61(2):290-298.
[9] 于玥, 凌诗颖, 帅瑞雪,等. 720例甲基丙二酸血症MMACHC基因c.609G>A突变患者临床特征及随访分析[J]. 浙江大学学报(医学版), 2021, 50(4):436-443.
Yu Y, Ling SY, Shuai RX, et al. Clinical characteristics and follow-up analysis of 720 patients with c.609G> A mutation[J].J Zhejiang Univ Med, 2021,50 (4): 436-443.
[10] 王随力,温志红,梁珍花,等. 先天性肾上腺皮质增生症患者家系基因分析[J]. 中国继续医学教育,2020,12(7):97-99.
Wang S, Wen ZH, Liang ZH, et al. Family gene analysis of patients with congenital adrenocorticohyperplasia[J]. Chin Cont Medl Edu, 2020,12 (7): 97-99.
[11] 刘怡,刘玉鹏,等.中国1003例甲基丙二酸血症的复杂临床表型、基因型及防治情况分析[J].中华儿科杂志,2018,56(6):414-420.
Liu Y, Liu YP, et.al. Analysis of the complex clinical phenotype, genotype and control of 1003 methylmalonic acidemia in China[J]. Chin J Pediatr, 2018,56(6):414-420.
[12] 肖丽,黄薇.先天性肾上腺皮质增生症21-羟化酶缺陷的诊断[J].实用妇产科杂志,2021,37(6):401-403.
Xiao L, Huang W. Diagnosis of congenital 21-hydroxylase deficiency[J]. J Pract Obstet Gynaecol, 2021,37 (6): 401-403.
[13] 吕媛媛.继发性肾上腺皮质功能减退症临床分析[J].临床荟萃,2010,25(19):1705-1706.
Lu YY. Clinical analysis of secondary adrenocortical dysfunction[J]. Clin Focus, 2010,25 (19): 1705-1706.
[14] Annane D, Pastores SM, Rochwerg B,et.al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part Ⅰ): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017[J]. Intensive Care Med,2017,43(12):1751-1763.
[15] 刘玉鹏,丁圆,李溪远,等.甲基丙二酸尿症合并先天性肾上腺皮质增生症1例报告[J].临床儿科杂志,2016,34(3):208-211.
Liu YP, Ding Y, Li XY, et.al. One case report of methylmalonuria combined with congenital adrenocortical hyperplasia[J]. J Clin Ped, 2016,34(3): 208-211.